Debt-to-equity of Fortress Biotech, Inc. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Fortress Biotech, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • Fortress Biotech, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 366%, a 51% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Fortress Biotech, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 366% -384% -51% 30 Sep 2025
Q2 2025 503% -319% -39% 30 Jun 2025
Q1 2025 704% -157% -18% 31 Mar 2025
Q4 2024 725% -82% -10% 31 Dec 2024
Q3 2024 750% +10% +1.4% 30 Sep 2024
Q2 2024 822% +254% +45% 30 Jun 2024
Q1 2024 861% +436% +103% 31 Mar 2024
Q4 2023 806% +484% +150% 31 Dec 2023
Q3 2023 740% +501% +210% 30 Sep 2023
Q2 2023 568% +356% +168% 30 Jun 2023
Q1 2023 424% +240% +130% 31 Mar 2023
Q4 2022 322% +158% +96% 31 Dec 2022
Q3 2022 238% +79% +50% 30 Sep 2022
Q2 2022 212% +72% +52% 30 Jun 2022
Q1 2022 184% +32% +21% 31 Mar 2022
Q4 2021 164% -26% -14% 31 Dec 2021
Q3 2021 159% -103% -39% 30 Sep 2021
Q2 2021 139% -265% -66% 30 Jun 2021
Q1 2021 152% -336% -69% 31 Mar 2021
Q4 2020 190% -371% -66% 31 Dec 2020
Q3 2020 262% -429% -62% 30 Sep 2020
Q2 2020 405% -190% -32% 30 Jun 2020
Q1 2020 488% -41% -7.7% 31 Mar 2020
Q4 2019 561% +114% +26% 31 Dec 2019
Q3 2019 691% +370% +116% 30 Sep 2019
Q2 2019 594% +282% +90% 30 Jun 2019
Q1 2019 529% +280% +113% 31 Mar 2019
Q4 2018 447% +240% +116% 31 Dec 2018
Q3 2018 320% +118% +58% 30 Sep 2018
Q2 2018 313% +137% +78% 30 Jun 2018
Q1 2018 249% +69% +39% 31 Mar 2018
Q4 2017 207% +57% +38% 31 Dec 2017
Q3 2017 203% +100% +97% 30 Sep 2017
Q2 2017 176% +102% +139% 30 Jun 2017
Q1 2017 179% +118% +194% 31 Mar 2017
Q4 2016 150% +95% +171% 31 Dec 2016
Q3 2016 103% +58% +126% 30 Sep 2016
Q2 2016 74% +36% +96% 30 Jun 2016
Q1 2016 61% +29% +93% 31 Mar 2016
Q4 2015 55% +29% +110% 31 Dec 2015
Q3 2015 46% +20% +79% 30 Sep 2015
Q2 2015 38% +13% +55% 30 Jun 2015
Q1 2015 32% +4.9% +18% 31 Mar 2015
Q4 2014 26% -5.7% -18% 31 Dec 2014
Q3 2014 25% -16% -39% 30 Sep 2014
Q2 2014 24% -37% -60% 30 Jun 2014
Q1 2014 27% -28% -51% 31 Mar 2014
Q4 2013 32% -16% -33% 31 Dec 2013
Q3 2013 42% +7.9% +23% 30 Sep 2013
Q2 2013 61% -22% -26% 30 Jun 2013
Q1 2013 55% 31 Mar 2013
Q4 2012 48% 31 Dec 2012
Q3 2012 34% 30 Sep 2012
Q2 2012 83% 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.